Enter multiple symbols separated by commas

Latest Video

An employee checks his Apple Inc. iPhone while working at LinkedIn Corp. headquarters in Mountain View, California.

The "Fast Money" traders give you 4 trades in the Internet sector focused on social and security.

The man behind Mayweather   Thu, 30 Apr '15 | 5:40 PM ET
The man behind Mayweather

Leonard Ellerbe, Mayweather Promotions CEO, discusses promoting and preparing for Floyd Mayweather's fight against Manny Pacquiao. Ellerbe says the sport of boxing is here to stay.

Fast Money Final Trade: AAPL, SWKS, GLNG & FCX

The Fast Money traders share their final trades of the day.

Guy on the street: Real winners of the fight

FM trader Guy Adami takes to Times Square to poll who will win Saturday's fight between Floyd Mayweather and Manny Pacquiao. The FM traders play the media space.

Options Action: Lowe's gets hammered   Thu, 30 Apr '15 | 5:45 PM ET
Options Action: Lowe's gets hammers

Dissecting a bearish bet on Lowe's, with CNBC contributor Mike Khouw.

Tesla's new charge   Thu, 30 Apr '15 | 5:40 PM ET
Tesla's new charge

Ahead of Tesla's big battery announcement, Dan Galves, Credit Suisse, remains bullish on the stock with an outperform rating.

Earnings playbook: GILD, FEYE & FSLR   Thu, 30 Apr '15 | 5:23 PM ET
Earnings playbook: GILD, FEYE & FSLR

The play on First Solar, Gilead and FireEye, with the FM traders.

LinkedIn tanks on guidance   Thu, 30 Apr '15 | 5:30 PM ET
LinkedIn tanks on guidance

LinkedIn shares lower after reporting its quarterly report. Colin Gillis, BGC Financial, has a hold rating on the stock.

Power House: LA   Thu, 30 Apr '15 | 4:00 PM ET
Power House: LA

Power House takes a look at Los Angeles, CA with a focus on Westwood & BelAir. Jasia Bishop of Partners Trust has the details.

Selloff a screaming buy?   Thu, 30 Apr '15 | 5:06 PM ET
Selloff a screaming buy?

Is now the time to buy? Air Wald, Oppenheimer, goes off the charts.

Nasdaq black eyes   Thu, 30 Apr '15 | 5:00 PM ET
Nasdaq black eyes

Dissecting today's drag on the Nasdaq, with the Fast Money traders.

Is the market leadership changing?   Thu, 30 Apr '15 | 5:00 PM ET
Is the market leadership changing?

Are transport stocks and biotechs giving up their market leadership? Andrew Burkly of Oppenheimer and Rich Ross of Evercore ISI discuss with Brian Sullivan.

Manny Pacquiao: Mayweather fight for the fans

WBO welterweight champ Manny Pacquiao is excited for Saturday's fight against Floyd Mayweather, Jr., and says he plans to give some of his earnings to a foundation in the Philippines.

Sell bonds, not stocks, in May?   Thu, 30 Apr '15 | 5:00 PM ET
Sell bonds, not stocks, in May?

Andrew Burkly of Oppenheimer and Rich Ross of Evercore ISI call the next move for the bond market.

The man who took on UBS   Thu, 30 Apr '15 | 4:37 PM ET
The man who took on UBS

CNBC's Eamon Javers spoke with the $104 million whistleblower, Bradley Birkenfeld.

Millennials pile into IRAs   Thu, 30 Apr '15 | 4:25 PM ET
Millennials pile into IRAs

Millennials are ramping up retirement savings and putting more money into Roth IRA accounts, reports CNBC's Sharon Epperson.

American homeowner dream still intact?   Thu, 30 Apr '15 | 4:19 PM ET
American homeowner dream still intact?

The Census Bureau is reporting home-ownership in the first quarter of 2015 dropped to nearly 64 percent, the lowest in 25 years. Insight, with CNBC's Diana Olick and Shari Olefson, Carnegie Group founder.

Gilead beats on EPS and revenue   Thu, 30 Apr '15 | 4:05 PM ET
Gilead beats on EPS and revenue

Gilead is reporting EPS beat of $2.94 adjusted on revenue beat of $7.59 billion, with CNBC's Meg Tirrell and Christine Short, Estimize.

LinkedIn beats, but sinks on poor guidance   Thu, 30 Apr '15 | 4:05 PM ET
LinkedIn beats, but sinks on poor guidance

LinkedIn is reporting EPS beat of $0.57 on revenue beat of $638 million, with CNBC's Julia Boorstin and FM trader Guy Adami. But the stock was hit on poor guidance.

Commodities tomorrow: Crude closes in on $60

CNBC's Jackie DeAngelis discusses the day's activity in the commodities markets. Crude was up again today. Traders say oil seems to be stabilizing around $60, and could hit $70 by the end of the year.

Traders watch the dollar   Thu, 30 Apr '15 | 4:00 PM ET
Traders watch the dollar

U.S. Fed Policy is at direct odds with the European Central Bank, CNBC's Patti Domm discusses its impact on the dollar.

US considers adding N Korea back on terror list

CNBC's Morgan Brennan reports on the threats posed by North Korea.

Gartman: This could get ugly   Thu, 30 Apr '15 | 3:52 PM ET
Gartman: This could get ugly

Oliver Pursche, Bruderman Brothers CEO, and Dennis Gartman of the Gartman Letter, discuss the selloff in stocks.

Biotech bunking together   Thu, 30 Apr '15 | 3:46 PM ET
Biotech bunking together

Biotech is bunking up in Cambridge's hottest zip codes as an affordable way to be in the hotbed of research. Details, with CNBC's Meg Tirrell.

How Main Street is playing Wall Street   Thu, 30 Apr '15 | 3:36 PM ET
How Main Street is playing Wall Street

Gauging the pulse of the retail investor, with Kristen Ruby, Ruby Media Group CEO; Ben Banks, NC State student and Dorm Room Capital founder; and Roy Chastain, retired attorney.

Will Tesla's Musk deliver?   Thu, 30 Apr '15 | 3:27 PM ET
Will Tesla's Musk deliver?

Discussing the impact Elon Musk's announcement on battery storage plans may have on the stock, with Colin Langan, UBS auto analyst, and John Thompson, Vilas Capital CEO.

The $104 million whistleblower   Thu, 30 Apr '15 | 2:43 PM ET
The $104 million whistleblower

CNBC's Eamon Javers reports on the man who took on UBS.

Fast Money Trader Steve Grasso explains why he's buying a stock that's been heading toward zero the past 5 years.

IMAX Chinese box office tops domestic numbers

Richard Gelfond, IMAX CEO, discusses how business in China plays into the company's international strategy going forward.

Biotech land grab in Kendall Square   Thu, 30 Apr '15 | 2:56 PM ET
Biotech companies expand in Kendall Square

CNCB's Meg Tirrell reports on one of the biotechnology industry's capital cities. 130 life sciences companies occupy Kendall Square in Cambridge, Massachusetts.

Contact Latest Video


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Video and TV